Page last updated: 2024-08-17

cycloheximide and canagliflozin

cycloheximide has been researched along with canagliflozin in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chao, TI; Chen, KF; Chen, LJ; Chen, YL; Chu, PY; Hsieh, FS; Huang, CY; Hung, MH; Shih, CT; Tsai, MH	1

Other Studies

1 other study(ies) available for cycloheximide and canagliflozin

Article	Year
Canagliflozin inhibits growth of hepatocellular carcinoma via blocking glucose-influx-induced β-catenin activation. Cell death & disease, 2019, 05-29, Volume: 10, Issue:6 Topics: Animals; beta Catenin; Canagliflozin; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Cycloheximide; Down-Regulation; Glucose; Glucose Transporter Type 1; Humans; Liver Neoplasms; Mice; Phosphorylation; Protein Phosphatase 2; RNA Interference; RNA, Small Interfering; Sodium-Glucose Transporter 2; Transplantation, Heterologous; Wnt Signaling Pathway	2019

Article

Year

Canagliflozin inhibits growth of hepatocellular carcinoma via blocking glucose-influx-induced β-catenin activation.

Cell death & disease, 2019, 05-29, Volume: 10, Issue:6

Topics: Animals; beta Catenin; Canagliflozin; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Cycloheximide; Down-Regulation; Glucose; Glucose Transporter Type 1; Humans; Liver Neoplasms; Mice; Phosphorylation; Protein Phosphatase 2; RNA Interference; RNA, Small Interfering; Sodium-Glucose Transporter 2; Transplantation, Heterologous; Wnt Signaling Pathway

2019